培美替尼(pemigatinib)靶向药2121最新价格是多少？

Cholangiocarcinoma is a rare cancer that develops in the long, thin bile ducts that carry digestive juices from the liver to the gallbladder and small intestine. At the time of diagnosis, most patients with cholangiocarcinoma have an advanced stage, meaning they cannot undergo surgical treatment. For these patients, chemotherapy combinations have become the standard initial treatment. Fibrocyte growth factor receptor 2 (FGFR2) fusions are found in the tumors of approximately 9% to 14% of patients with cholangiocarcinoma. Today's approval applies to patients with locally advanced or metastatic cholangiocarcinoma whose tumors harbor FGFR2 gene fusions or other rearrangements. The tablets prevent the growth and spread of tumors by inhibiting FGFR2 in tumor cells.

The recommended dose of pemetinib is 13.5 mg orally daily for 14 days, followed by 7 days off in a 21-day cycle. Continue treatment until disease progression or unacceptable toxicity. Swallow the tablets whole, with or without food.

What is the latest price of pemigatinib targeted drug 2121? It is a pity that pemetinib has not been approved for marketing in China. Drugs that are not on the market have no way to enter the national medical insurance. Patients who want to use this drug have only one way to purchase drugs abroad. However, the manpower, material and financial resources consumed by purchasing drugs overseas are far beyond imagination, which gives many patients a headache. However, according to Medical Companion Travel, the version of pemetinib has been well received by many patients. The specification is 13.5 mg x 14 tablets and the price is around $341,175. Compared with it, it is more suitable for patients to use for a long time and is of high quality and low price. Due to the fluctuation of the exchange rate, which causes the price to rise and fall, the specific price is not very accurate for the time being. For more information about pemetinib, please contact Medical Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.